Human Health Holdings 과거 수익 실적

과거 기준 확인 2/6

Human Health Holdings은 연평균 23.3%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 증가했으며, 연간 11.2%였습니다. 매출은 연평균 12.9%의 비율로 증가했습니다. Human Health Holdings의 자기자본이익률은 3.2%이고 순이익률은 4.1%입니다.

주요 정보

23.3%

수익 성장률

23.2%

EPS 성장률

Healthcare 산업 성장	11.3%
매출 성장률	12.9%
자기자본 수익률	3.2%
순이익	4.1%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

수익 및 비용 분석

Human Health Holdings 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

SEHK:1419 수익, 비용 및 수입 (HKD Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	591	24	184
31 Mar 24	603	-22	192
31 Dec 23	616	-67	199
30 Sep 23	809	57	205
30 Jun 23	1,002	181	211
31 Mar 23	1,208	367	201
31 Dec 22	1,415	553	191
30 Sep 22	1,268	464	179
30 Jun 22	1,122	375	168
31 Mar 22	967	297	166
31 Dec 21	813	218	164
30 Sep 21	734	181	163
30 Jun 21	655	144	163
31 Mar 21	542	59	131
31 Dec 20	430	-27	100
30 Sep 20	442	-33	116
30 Jun 20	454	-40	133
31 Mar 20	492	-11	174
31 Dec 19	530	19	216
30 Sep 19	529	23	213
30 Jun 19	529	27	211
31 Mar 19	523	26	209
31 Dec 18	518	25	208
30 Sep 18	518	24	206
30 Jun 18	518	24	204
31 Mar 18	509	22	202
31 Dec 17	501	19	201
30 Sep 17	491	16	201
30 Jun 17	481	13	200
31 Mar 17	493	16	200
31 Dec 16	504	19	200
30 Sep 16	505	21	195
30 Jun 16	499	23	185
30 Sep 15	456	36	151
30 Jun 15	430	34	148
30 Jun 14	365	39	119

양질의 수익: 1419 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: 1419 의 현재 순이익 이익률 (4.1%) 작년보다 낮습니다 (18.1%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 1419 의 수익은 지난 5년 동안 매년 23.3% 씩 크게 증가했습니다.

성장 가속화: 1419 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: 1419 은 지난 1년 동안 마이너스 수익 성장( -86.6% )을 기록하여 Healthcare 업계 평균( -16.9% ).

Human Health Holdings 과거 수익 실적

과거 기준 확인 2/6

주요 정보

최근 과거 실적 업데이트

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Recent updates

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기